Veeva Announces Fiscal 2019 Third Quarter Results

16:05 EST 28 Nov 2018 | Businesswire
This article has expired, however you can still download the PDF.
Total Revenues of $224.7M, up 27% Year-over-year Subscription Services Revenues of $178.2M, up 25% Year-over-year Veeva Systems Inc. (NYSE: VEEV), a leading provider of industry cloud solutions for the global life s...

Other Sources for this Article

Investor Relations Contact:
Rick Lund
Veeva Systems Inc.

Media Contact:
Roger Villareal
Veeva Systems Inc.


More From BioPortfolio on "Veeva Announces Fiscal 2019 Third Quarter Results"

Quick Search

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Clinical Research Organization
Contract Research Organization (CRO) provide research services outsourced on a contract basis to the pharmaceutical, biotechnology, healthcare and medical device industries: biopharmaceutical development biologic assay development commercial...